(Corrects name of rare neurological disorder, to ATTRv-PN, in paragraph 9) By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca's long-time CEO Pascal Soriot has rarely put a foot wrong. The
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Trump removes 50% tariffs on Canadian products to try to boost to Maine companies
By David Shepardson WASHINGTON, Oct 23 (Reuters) - With an incumbent Maine US senator from…
Catlin, Lahiri, Pieters, Surratt poised for final day showdown in Hong Kong
VIDEO SHOWS: HIGHLIGHTS OF THE THIRD ROUND OF THE ASIAN TOUR HONG KONG OPEN RESENDING…
Tennis-Holder Rybakina sets up Fernandez clash in Ningbo final
Oct 24 (Reuters) - Defending Ningbo Open champion Elena Rybakina overcame Russian sixth seed Diana…
